Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Temple

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of the American Geriatrics Society|April 3, 2024
Closing the gap: A United States perspective on enhancing drug evaluation in older adultsS W Johnny Lau, Qi Liu, Rajanikanth Madabushi, et al.
JAMA Internal Medicine|February 15, 2021
Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by ApplicantsHarinder Singh Chahal, Sanjana Mukherjee, Daniel W Sigelman, et al.
The New England Journal of Medicine|May 23, 2019
Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New ClassJean Kim, Tiffany Farchione, Andrew Potter, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 28, 2019
Long-term soft tissue outcomes for hydroxyapatite-coated bone-anchored hearing implant surgeryTodd Kanzara, Hussein Walijee, Rashid Badar Sheikh, et al.
The New England Journal of Medicine|January 8, 2010
Erythropoiesis-stimulating agents--time for a reevaluationEllis F Unger, Aliza M Thompson, Melanie J Blank, et al.
Lancet (London, England)|August 23, 2011
Injectable extended-release naltrexone for opioid dependenceDouglas C Throckmorton, Robert Temple, Bob A Rappaport, et al.
Statistics in Medicine|May 4, 2004
Independence of the statistician who analyses unblinded dataJay P Siegel, Robert T O'Neill, Robert Temple, et al.
The American Journal of Psychiatry|January 9, 2014
Cardiac safety concerns remain for citalopram at dosages above 40 mg/daySteven T Bird, Victor Crentsil, Robert Temple, et al.
The New England Journal of Medicine|September 1, 2007
Rosiglitazone and the FDAHylton V Joffe, Mary H Parks, Robert J Meyer, et al.
The American Journal of Bioethics : AJOB|April 10, 2015
Right job, wrong tool: a commentary on designing clinical trials for Ebola virus diseaseRobert M Nelson, Michelle Roth-Cline, Kevin Prohaska, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of the American Geriatrics Society|April 3, 2024
Closing the gap: A United States perspective on enhancing drug evaluation in older adultsS W Johnny Lau, Qi Liu, Rajanikanth Madabushi, et al.
JAMA Internal Medicine|February 15, 2021
Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by ApplicantsHarinder Singh Chahal, Sanjana Mukherjee, Daniel W Sigelman, et al.
The New England Journal of Medicine|May 23, 2019
Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New ClassJean Kim, Tiffany Farchione, Andrew Potter, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 28, 2019
Long-term soft tissue outcomes for hydroxyapatite-coated bone-anchored hearing implant surgeryTodd Kanzara, Hussein Walijee, Rashid Badar Sheikh, et al.
The New England Journal of Medicine|January 8, 2010
Erythropoiesis-stimulating agents--time for a reevaluationEllis F Unger, Aliza M Thompson, Melanie J Blank, et al.
Lancet (London, England)|August 23, 2011
Injectable extended-release naltrexone for opioid dependenceDouglas C Throckmorton, Robert Temple, Bob A Rappaport, et al.
Statistics in Medicine|May 4, 2004
Independence of the statistician who analyses unblinded dataJay P Siegel, Robert T O'Neill, Robert Temple, et al.
The American Journal of Psychiatry|January 9, 2014
Cardiac safety concerns remain for citalopram at dosages above 40 mg/daySteven T Bird, Victor Crentsil, Robert Temple, et al.
The New England Journal of Medicine|September 1, 2007
Rosiglitazone and the FDAHylton V Joffe, Mary H Parks, Robert J Meyer, et al.
The American Journal of Bioethics : AJOB|April 10, 2015
Right job, wrong tool: a commentary on designing clinical trials for Ebola virus diseaseRobert M Nelson, Michelle Roth-Cline, Kevin Prohaska, et al.
Pageof 9